Have a feature idea you'd love to see implemented?
Let us know!
HURA TuHURA Biosciences Inc.
Price (delayed)
$3.35
Market cap
$141.65M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$9.77
Enterprise value
$138.63M
Highlights
TuHURA Biosciences's EPS has soared by 96% YoY and by 13% from the previous quarter
The net income rose by 42% YoY and by 10% QoQ
TuHURA Biosciences's equity has soared by 184% YoY but it has plunged by 55% from the previous quarter
The quick ratio has contracted by 38% from the previous quarter
Key stats
What are the main financial stats of HURA
Market
Valuations
Earnings
Shares outstanding
42.28M
Market cap
$141.65M
Enterprise value
$138.63M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.12
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$7.71M
EBITDA
-$7.65M
Free cash flow
-$7.77M
Per share
Balance sheet
Liquidity
EPS
-$9.77
Free cash flow per share
-$4.9
Book value per share
$1.07
Revenue per share
$0
TBVPS
$2.61
Total assets
$4.14M
Total liabilities
$2.45M
Debt
$0
Equity
$1.7M
Working capital
$1.23M
Debt to equity
0
Current ratio
1.54
Quick ratio
1.34
Net debt/EBITDA
0.39
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-153.3%
Return on equity
-269%
Return on invested capital
N/A
Return on capital employed
-409.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HURA stock price
How has the TuHURA Biosciences stock price performed over time
Intraday
1.82%
1 week
-31.63%
1 month
-39.42%
1 year
-99.2%
YTD
-98.39%
QTD
-98.6%
Financial performance
How have TuHURA Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$7.7M
Net income
-$7.52M
Gross margin
N/A
Net margin
N/A
The net income rose by 42% YoY and by 10% QoQ
TuHURA Biosciences's operating income has increased by 41% YoY and by 9% QoQ
Growth
What is TuHURA Biosciences's growth rate over time
Valuation
What is TuHURA Biosciences stock price valuation
P/E
N/A
P/B
3.12
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
TuHURA Biosciences's EPS has soared by 96% YoY and by 13% from the previous quarter
TuHURA Biosciences's equity has soared by 184% YoY but it has plunged by 55% from the previous quarter
The P/B is 27% lower than the 5-year quarterly average of 4.3
Efficiency
How efficient is TuHURA Biosciences business performance
HURA's return on equity has surged by 54% year-on-year and by 41% since the previous quarter
HURA's ROA is up by 36% YoY and by 23% QoQ
Dividends
What is HURA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HURA.
Financial health
How did TuHURA Biosciences financials performed over time
The total assets is 69% more than the total liabilities
The total assets has soared by 180% YoY but it has contracted by 33% from the previous quarter
The quick ratio has contracted by 38% from the previous quarter
The debt is 100% smaller than the equity
TuHURA Biosciences's equity has soared by 184% YoY but it has plunged by 55% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.